Department of Women's and Children's Health, Karolinska Institute, Stockholm, Sweden.
Pediatric Endocrinology Unit, Karolinska University Hospital, Stockholm, Sweden.
Endocrinol Metab (Seoul). 2022 Aug;37(4):587-598. doi: 10.3803/EnM.2022.1528. Epub 2022 Jul 8.
A plethora of negative long-term outcomes have been associated with congenital adrenal hyperplasia (CAH). The causes are multiple and involve supra-physiological gluco- and mineralocorticoid replacement, excess adrenal androgens both intrauterine and postnatal, elevated steroid precursor and adrenocorticotropic hormone levels, living with a congenital condition as well as the proximity of the cytochrome P450 family 21 subfamily A member 2 (CYP21A2) gene to other genes. This review aims to discuss the different long-term outcomes of CAH.
先天性肾上腺皮质增生症(CAH)与诸多负面的长期后果相关。其病因众多,涉及超生理剂量的糖和盐皮质激素替代治疗、宫内和产后的过量肾上腺雄激素、升高的类固醇前体和促肾上腺皮质激素水平、先天性疾病的存在以及细胞色素 P450 家族 21 亚家族 A 成员 2(CYP21A2)基因与其他基因的邻近关系。本文旨在讨论 CAH 的不同长期后果。